Patents
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
03/2010
03/10/2010EP2161267A1 A process for stereoselective synthesis of lamivudine
03/09/2010US7674823 DNA-PK inhibitors
03/04/2010WO2010023676A2 Process for preparing lamivudine polymorph form
02/2010
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/23/2010US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases
02/16/2010US7662811 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
02/16/2010CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
02/11/2010WO2010016230A1 Sulfoxyimino-substituted benzoyl derivative and herbicide
02/09/2010US7659280 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2291065C Raf kinase inhibitors
02/02/2010US7655665 Nitromethylene derivatives and their use
01/2010
01/12/2010CA2439831C Polymorphic and other crystalline forms of cis-ftc
01/07/2010US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles
01/06/2010CN101619057A N-substituted piperidine derivatives as serotonin receptor agents
01/05/2010US7642354 Polycyclic pyrazines as potassium ion channel modulators
12/2009
12/29/2009US7638515 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
12/29/2009CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/24/2009US20090318472 Aminopyrazine derivatives and compositions
12/23/2009EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/22/2009CA2114221C 1, 3-oxathiolane nucleoside analogues
12/15/2009CA2481078C Method and compositions for the synthesis of bch-189 and related compounds
12/10/2009US20090306114 Polymorphic and Other Crystalline Forms of Cis-FTC
12/09/2009EP2130820A1 Antipruritics
12/09/2009CN101597281A Preparation method of lamivudine and intermediate thereof
12/08/2009US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
11/2009
11/19/2009US20090286787 Substituted gamma lactams as therapeutic agents
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/12/2009WO2009084033A3 Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
11/11/2009EP1477186B1 Antipruritics
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
10/2009
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/28/2009CN101568534A Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through GLK
10/22/2009WO2009127996A1 Novel crystalline form of lamivudine
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548988C Metabolites of ecteinascidin 743
10/14/2009CN100548987C Pesticidal pyridinecarboxamide derivatives
10/06/2009US7598397 Sulfonamide peri-substituted bicyclics for occlusive artery disease
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/01/2009WO2009118765A2 Novel monoamine re-uptake inhibitor
10/01/2009US20090247487 Combination Therapy to Treat Hepatitis B Virus
10/01/2009US20090246819 Assay Methods Using Chemiluminescent Detection of Peroxidase
09/2009
09/30/2009CN101544632A Lamivudine diastereoselective synthesis method
09/29/2009US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example
09/29/2009US7595319 Compounds having selective inhibiting effect at GSK3
09/24/2009WO2009116055A1 Lamivudine : zidovudine : water 1 : 1 : 1 cocrystal
09/23/2009CN100542535C Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues
09/22/2009CA2209640C Cycloalkano-pyridines
09/16/2009CN101531656A Lamivudine crystal form and preparation method thereof
09/11/2009WO2009111635A2 Dithiol compounds, derivatives, and uses therefor
09/11/2009WO2009111633A2 Mercaptan and seleno-mercaptan compounds and methods of using them
09/11/2009WO2009005338A8 Solid forms ult-i, ult-2 and ult-3 of emtricitabine
09/08/2009US7585853 Compounds having selective inhibiting effect at GSK3
09/02/2009EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase
09/01/2009US7582589 3-carbonylaminothiophenes and their use as fungicides
08/2009
08/27/2009US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/27/2009US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
08/18/2009US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression
08/18/2009US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer
08/18/2009US7576088 Benzodioxole derivatives
08/18/2009US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction
08/18/2009US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine)
08/13/2009WO2009037538A3 Process for the preparation of lamivudine form i
08/12/2009EP2086964A2 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk
08/12/2009CN101506206A Inhibitors of Akt activity
08/12/2009CN100526310C Cyclopropyl-thienyl-carboxamide as fungicides
08/11/2009US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent
08/06/2009US20090197925 O-cyclopropyl-carboxanilides and their use
07/2009
07/30/2009US20090192310 Process and Intermediates for Preparing Emtricitabine
07/23/2009WO2009005338A3 Solid forms ult-i, ult-2 and ult-3 of emtricitabine
07/23/2009US20090186932 Pesticidal N-Phenylpyrazole Derivatives
07/22/2009CN100516066C Compounds for treating impaired fundic relaxation
07/16/2009WO2009058800A3 Synthesis of nucleosides
07/14/2009US7560556 Assay methods using chemiluminescent detection of peroxidase
07/14/2009US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
07/14/2009US7560462 Compounds useful for inhibiting CHK1
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/14/2009US7560456 Pesticidal pyridinecarboxamide derivatives
07/14/2009US7560451 Aspartyl protease inhibitors
07/09/2009WO2009084033A2 Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
07/09/2009US20090176801 Novel lapachone compounds and methods of use thereof
07/08/2009CN100509804C N-substituted piperidine derivatives as serotonin receptor agents
07/02/2009US20090171086 2,4-pyrimidinediamine compounds and their uses
06/2009
06/25/2009WO2009077954A1 Aminopyrazole derivatives
06/25/2009CA2706836A1 Aminopyrazole derivatives
06/18/2009WO2009074019A1 Proteinase inhibitors useful for treating cancer
06/18/2009US20090156628 Aminothiazoles and their Uses
06/18/2009US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
06/16/2009US7547782 Met kinase inhibitors
06/09/2009US7544692 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus
06/04/2009WO2009069014A1 Amorphous lamivudine and its preparation
06/04/2009WO2009069013A1 Crystalline form i of lamivudine and its preparation
06/04/2009WO2009069012A1 Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
06/04/2009WO2009069011A1 Process for the preparation of substituted 1,3-oxathiolanes
06/02/2009US7541472 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
06/02/2009US7541368 Pyrazoles as inhibitors of tumor necrosis factor
05/2009
05/28/2009US20090137570 Inhibitors of cathepsin s
05/22/2009WO2009010260A3 Condensed anthranilamide insecticides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 25